Skip to content

FYTEKO

Active
Public limited companyfounded 201412 yrs activeResearchdreef 4, 1070 Anderlecht, BelgiumKBO/BCE: BE 0552.915.242
Summary

FYTEKO has been active since 2014 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €10.0m and a net result of -€2.4m. Equity is growing by ~11.6% per year across the filed fiscal years. Its solvency ranks better than 80% of 197 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.8% (low).

Checked score

Score 2025
Axes · tick = 2024
Profitability0▼-2
Solvency100=
Growth52=
Track record100
Bankruptcy probability, 12 months
0.8% Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €550,000 at 30 days acceptable
Liquidity ample (current ratio 8.1 against 15.91 in 2024; short-term debt: 9.5% and cash: 1.2% of total assets), and 14.9% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Eight signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
raises risk · Multiple establishment units
Several establishment units mean more fixed costs, and such companies fail more often than a company with one establishment.
KBO · establishment units
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 72
Relative position
BE, all sectors
reference
Scientific research and development (NACE 72)
about 30% fewer bankruptcies
← fewer bankruptcies more bankruptcies →
lowers risk · Lower-risk legal form
Companies with this legal form statistically fail less often than a BV.
KBO · legal form
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
85.1%
Return on assets
-20.2%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 12 years 0 20 y
raises risk · Persistent losses
Two consecutive loss-making years (2024 and 2025); equity is also lower. May indicate structural pressure on profitability.
NBB · annual accounts 2025
Net result per financial year
1819202122232425
2018 to 2025 · latest year -€2.4m
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 16-07-2026, 15 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
15 d early
2024
22 d early
2023
16 d early
2022
41 d early
2021
19 d early
2020
2 d early
2019
24 d late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 13 days before the deadline; the sector median for financial year 2024 is 13 days before the deadline, and 32% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 12 July (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Position in the running window
01-10-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

FYTEKO was incorporated on 23 May 2014.1 Since 2026, Carlos Rodriguez-Villa Förster has served as director of the company.2 Total assets rose from EUR 2.8 million in 2018 to EUR 12 million in 2025 and headcount from 3.3 to 15.7 full-time equivalents.3

  1. 1Crossroads Bank for Enterprises
  2. 2Belgian State Gazette, 17-08-2026
  3. 3National Bank, annual accounts 2018 and 2025

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, full schema

Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
-€2.4m▼ 28.0%
2024 · -€1.8m
Working capital
€7.9m▼ 27.0%
2024 · €10.8m
Trend over the years
In euros
In per cent
Ratio
In full-time equivalents (FTE)
In euros
No line ticked in this group.
In per cent
No line ticked in this group.
Ratio
No line ticked in this group.
In full-time equivalents (FTE)
No line ticked in this group.

Untick a line to hide it. Point at a year (or use the arrow keys on the chart) for the exact figures; the table below gives them all.Sector: the middle half (P25 to P75) of NACE 72, Scientific research and development, each year against the same schema; no band under 30 filings. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA), Staff (FTE).

Every figure with its change against the fiscal year before
favourable unfavourable
Line20212022202320242025
Operating result-€62,113▲ 85.3%-€755,007▼ 1,116%-€1.2m▼ 56.8%-€1.9m▼ 58.7%-€2.9m▼ 52.5%
Net result€294,844above the sector's middle half-€369,321below the sector's middle half-€808,738below the sector's middle half▼ 119%-€1.8mbelow the sector's middle half▼ 129%-€2.4mbelow the sector's middle half▼ 28.0%
Equity€2.6mabove the sector's middle half▲ 26.7%€2.7mwithin the sector's middle half▲ 2.3%€1.6mwithin the sector's middle half▼ 39.7%€12.5mabove the sector's middle half▲ 668%€10.0mabove the sector's middle half▼ 20.4%
Total assets€3.6mabove the sector's middle half▲ 22.2%€5.6mwithin the sector's middle half▲ 54.1%€5.5mwithin the sector's middle half▼ 1.0%€14.1mabove the sector's middle half▲ 155%€11.7mwithin the sector's middle half▼ 17.0%
Debt€793,081▼ 1.5%€2.6m▲ 222%€3.6m▲ 42.9%€1.3m▼ 63.8%€1.6m▲ 22.6%
Working capital€1.0mabove the sector's middle half▼ 8.2%€2.7mwithin the sector's middle half▲ 165%€2.4mwithin the sector's middle half▼ 9.1%€10.8mabove the sector's middle half▲ 345%€7.9mabove the sector's middle half▼ 27.0%
Solvency72.9%within the sector's middle half▲ 2.6pp48.4%within the sector's middle half▼ 24.5pp29.5%within the sector's middle half▼ 18.9pp88.7%above the sector's middle half▲ 59.2pp85.1%above the sector's middle half▼ 3.6pp
Current ratio2.27within the sector's middle half▼ 0.099.78above the sector's middle half▲ 7.527.79above the sector's middle half▼ 1.9915.91above the sector's middle half▲ 8.128.10above the sector's middle half▼ 7.81
Return on assets (ROA)8.1%within the sector's middle half▲ 14.6pp-6.6%within the sector's middle half▼ 14.8pp-14.6%below the sector's middle half▼ 8.0pp-13.1%within the sector's middle half▲ 1.5pp-20.2%below the sector's middle half▼ 7.1pp
Staff (FTE)8.7▲ 26.1%11.1within the sector's middle half▲ 27.6%14.2within the sector's middle half▲ 27.9%11.8within the sector's middle half▼ 16.9%15.7within the sector's middle half▲ 33.1%
above within below the middle half (P25 to P75) of NACE 72, Scientific research and development, each year against the same schema; no band under 30 filings.
Result per fiscal year
Operating resultNet result
-€3.0m-€2.0m-€1.0m€0Operating result 2021: -€62,113-€62,113Net result 2021: €294,844€294,844Operating result 2022: -€755,007-€755,007Net result 2022: -€369,321-€369,321Operating result 2023: -€1.2m-€1.2mNet result 2023: -€808,738-€808,738Operating result 2024: -€1.9m-€1.9mNet result 2024: -€1.8m-€1.8mOperating result 2025: -€2.9m-€2.9mNet result 2025: -€2.4m-€2.4m20212022202320242025-€3m-€2m-€1m€0Operating result 2023: -€1.2m-€1.2mNet result 2023: -€808,738-€809,000Operating result 2024: -€1.9m-€1.9mNet result 2024: -€1.8m-€1.8mOperating result 2025: -€2.9m-€2.9mNet result 2025: -€2.4m-€2.4m202320242025
The operating result stays negative: a loss of €2.9m in 2025 against €1.9m in 2024; the loss grows and 2025 has the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €11.7m
Fixed assets €2.7m ▲ 4.8%
Current assets €9.0m ▼ 22.0%
Equity and liabilities €11.7m
Equity €10.0m ▼ 20.4%
Provisions €125,623 ▼ 54.5%
Debt €1.6m ▲ 22.6%
Debt's share of the balance-sheet total rises from 9.4% to 13.9%. Equity is lower and debt is higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
-€1.8m▼
2024 · -€967,820
Cash flow
-€1.3m▼
2024 · -€936,878
Quick ratio
7.84▼
2024 · 15.42
Debt to equity
0.16▲
2024 · 0.11
ROE
-23.8%▼
2024 · -14.8%
Interest coverage
-31.51▼
2024 · -2.27
Debt ≤ 1 year
€1.1m▲
2024 · €723,328
Debt > 1 year
€333,333▼
2024 · €416,667
Income taxes
-€5,663▲
2024 · -€47,871
Staff costs
€1.6m▲
2024 · €1.1m
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 376 companies that looked in July 2024 the way this one looks now, 0.8% went bankrupt within 24 months and 92% are still going.

  • Small
  • 10 to 20 years old
  • solvency 30% or more
  • a loss of 10% of the balance sheet or more
0.8% went bankrupt
7.2% stopped otherwise
92% still going

A further 0.3% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a bankruptcy probability of 0.8% over twelve months; the group does not contradict it.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,341 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 376 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 62 lines
Balance sheet Code20242025
Assets
Total assets20/58€14.1m€11.7m▼
Fixed assets21/28€2.6m€2.7m▲
Intangible fixed assets21€2.5m€2.6m▲
Tangible fixed assets22/27€74,608€147,184▲
Plant, machinery and equipment23€72,838€127,872▲
Furniture and vehicles24€1,770€19,312▲
Financial fixed assets28€2,612€9,870▲
Current assets29/58€11.5m€9.0m▼
Stocks and contracts in progress3€357,914€294,068▼
Stocks30/36€357,914€294,068▼
Amounts receivable within one year40/41€697,861€929,875▲
Trade receivables40€429,768€629,131▲
Other amounts receivable41€268,093€300,744▲
Current investments50/53-€7.5m
Cash at bank and in hand54/58€10.4m€143,219▼
Deferred charges and accrued income490/1€29,043€113,924▲
Equity and liabilities
Total equity and liabilities10/49€14.1m€11.7m▼
Equity10/15€12.5m€10.0m▼
Contributions10/11€14.9m€14.9m=
Capital10€14.9m€14.9m=
Issued capital100€14.9m€14.9m=
Reserves13€114€114=
Non-distributable reserves130/1€114€114=
Legal reserve130€114€114=
Profit (loss) carried forward14-€2.8m-€5.2m▼
Investment grants15€480,340€295,185▼
Provisions and deferred taxes16€276,124€125,623▼
Provisions for liabilities and charges160/5€125,623€125,623=
Other liabilities and charges164/5€125,623€125,623=
Deferred taxes168€150,501€0▼
Amounts payable17/49€1.3m€1.6m▲
Amounts payable after more than one year17€416,667€333,333▼
Financial debts170/4€416,667€333,333▼
Amounts payable within one year42/48€723,328€1.1m▲
Current portion of amounts payable after more than one year42€83,684€104,167▲
Financial debts43€250,000€312,645▲
Credit institutions430/8€250,000€312,645▲
Trade debts44€221,784€377,059▲
Suppliers440/4€221,784€377,059▲
Taxes, remuneration and social security45€83,795€183,778▲
Remuneration and social security454/9€83,795€183,778▲
Other amounts payable47/48€84,065€131,074▲
Accrued charges and deferred income492/3€182,241€179,650▼
Income statement Code20242025
Non-recurring operating income76A€851€0▼
Remuneration, social security and pensions62€1.1m€1.6m▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€911,712€1.1m▲
Other operating charges640/8€2,682€196,230▲
Non-recurring operating charges66A€125,623€0▼
Gross operating margin9900€214,091-€44,457▼
Operating profit (loss)9901-€1.9m-€2.9m▼
Financial income75/76B€312,646€552,055▲
Recurring financial income75€312,646€552,055▲
Financial charges65/66B€426,239€56,963▼
Recurring financial charges65€426,239€56,963▼
Profit (loss) for the period before taxes9903-€2.0m-€2.4m▼
Transfer from deferred taxes780€96,663€0▼
Income taxes67/77-€47,871-€5,663▲
Profit (loss) for the period9904-€1.8m-€2.4m▼
Profit (loss) for the period to be appropriated9905-€1.8m-€2.4m▼
Appropriation of the result
Profit (loss) to be appropriated9906-€2.8m-€5.2m▼
Profit (loss) brought forward from the previous period14P-€1.0m-€2.8m▼
Social balance
Average headcount (FTE)908711.815.7▲

The notes to these accounts (20 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20212022202320242025Change
Non-recurring operating income76A---€851€0▼ 100%
Remuneration, social security and pensions62€606,813€883,696€1.1m€1.1m€1.6m▲ 47.5%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€428,996€639,215€820,982€911,712€1.1m▲ 17.6%
Other operating charges640/8€4,012€4,435€1,870€2,682€196,230▲ 7,216%
Non-recurring operating charges66A---€125,623€0▼ 100%
Gross operating margin9900€977,708€772,339€768,659€214,091-€44,457▼ 121%
Operating profit (loss)9901-€62,113-€755,007-€1.2m-€1.9m-€2.9m▼ 52.5%
Financial income75/76B€277,584€305,164€312,904€312,646€552,055▲ 76.6%
Recurring financial income75€277,584€305,164€312,904€312,646€552,055▲ 76.6%
Financial charges65/66B€7,444€28,902€74,615€426,239€56,963▼ 86.6%
Recurring financial charges65€7,444€28,902€74,615€426,239€56,963▼ 86.6%
Profit (loss) for the period before taxes9903€208,027-€478,746-€945,740-€2.0m-€2.4m▼ 19.0%
Transfer from deferred taxes780€58,782€70,792€96,173€96,663€0▼ 100%
Income taxes67/77-€28,035-€38,633-€40,829-€47,871-€5,663▲ 88.2%
Profit (loss) for the period9904€294,844-€369,321-€808,738-€1.8m-€2.4m▼ 28.0%
Profit (loss) for the period to be appropriated9905€294,844-€369,321-€808,738-€1.8m-€2.4m▼ 28.0%
Line20212022202320242025Change
Assets
Total assets20/58€3.6m€5.6m€5.5m€14.1m€11.7m▼ 17.0%
Fixed assets21/28€1.8m€2.6m€2.7m€2.6m€2.7m▲ 4.8%
Intangible fixed assets21€1.7m€2.5m€2.6m€2.5m€2.6m▲ 1.8%
Tangible fixed assets22/27€80,603€135,364€109,974€74,608€147,184▲ 97.3%
Plant, machinery and equipment23€75,287€129,278€106,835€72,838€127,872▲ 75.6%
Furniture and vehicles24€5,316€6,086€3,140€1,770€19,312▲ 991%
Financial fixed assets28€2,842€2,842€3,217€2,612€9,870▲ 278%
Current assets29/58€1.8m€3.0m€2.8m€11.5m€9.0m▼ 22.0%
Stocks and contracts in progress3€157,175€360,973€394,193€357,914€294,068▼ 17.8%
Stocks30/36€157,175€360,973€394,193€357,914€294,068▼ 17.8%
Amounts receivable within one year40/41€433,438€698,774€592,586€697,861€929,875▲ 33.2%
Trade receivables40€299,780€302,244€371,800€429,768€629,131▲ 46.4%
Other amounts receivable41€133,658€396,530€220,786€268,093€300,744▲ 12.2%
Current investments50/53----€7.5m-
Cash at bank and in hand54/58€1.2m€1.9m€1.8m€10.4m€143,219▼ 98.6%
Deferred charges and accrued income490/1€13,106€13,579€21,382€29,043€113,924▲ 292%
Equity and liabilities
Total equity and liabilities10/49€3.6m€5.6m€5.5m€14.1m€11.7m▼ 17.0%
Equity10/15€2.6m€2.7m€1.6m€12.5m€10.0m▼ 20.4%
Contributions10/11€2.5m€1.8m€1.8m€14.9m€14.9m=
Capital10€2.5m€1.8m€1.8m€14.9m€14.9m=
Issued capital100€2.5m€1.8m€1.8m€14.9m€14.9m=
Reserves13€114€114€114€114€114=
Non-distributable reserves130/1€114€114€114€114€114=
Legal reserve130€114€114€114€114€114=
Profit (loss) carried forward14-€580,291-€191,321-€1.0m-€2.8m-€5.2m▼ 83.1%
Investment grants15€678,119€1.0m€784,375€480,340€295,185▼ 38.5%
Provisions and deferred taxes16€190,038€328,648€247,165€276,124€125,623▼ 54.5%
Provisions for liabilities and charges160/5---€125,623€125,623=
Other liabilities and charges164/5---€125,623€125,623=
Deferred taxes168€190,038€328,648€247,165€150,501€0▼ 100%
Amounts payable17/49€793,081€2.6m€3.6m€1.3m€1.6m▲ 22.6%
Amounts payable after more than one year17-€2.3m€3.3m€416,667€333,333▼ 20.0%
Financial debts170/4-€2.3m€3.3m€416,667€333,333▼ 20.0%
Amounts payable within one year42/48€793,081€303,433€356,776€723,328€1.1m▲ 53.3%
Current portion of amounts payable after more than one year42---€83,684€104,167▲ 24.5%
Financial debts43---€250,000€312,645▲ 25.1%
Credit institutions430/8---€250,000€312,645▲ 25.1%
Trade debts44€60,077€171,548€171,436€221,784€377,059▲ 70.0%
Suppliers440/4€60,077€171,548€171,436€221,784€377,059▲ 70.0%
Taxes, remuneration and social security45€71,098€95,714€99,608€83,795€183,778▲ 119%
Taxes450/3€218€0----
Remuneration and social security454/9€70,880€95,714€99,608€83,795€183,778▲ 119%
Other amounts payable47/48€661,907€36,171€85,732€84,065€131,074▲ 55.9%
Accrued charges and deferred income492/3--€42,418€182,241€179,650▼ 1.4%
Line20212022202320242025Change
Profit (loss) for the period9904€294,844-€369,321-€808,738-€1.8m-€2.4m▼ 28.0%
+ Depreciation and write-downs630€428,996€639,215€820,982€911,712€1.1m▲ 17.6%
Operating cash flow (approximation)€723,840€269,894€12,244-€936,878-€1.3m▼ 38.1%
Investment in fixed assets (approximation)--€1.4m-€951,722-€764,533-€1.2m▼ 56.5%
Change in cash-€700,518-€122,704€8.7m-€10.3m▼ 219%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
17-08
State Gazette act Appointment: Carlos Rodriguez-Villa Förster (director)
Resignation: Rico Toft CHRISTENSEN (director) · Permanent representative: Guillaume Wégria4 facts ▸
  • Board meeting, 25-06-2026
  • Director appointment, Carlos Rodriguez-Villa Förster (director)
  • Director resignation, Rico Toft CHRISTENSEN (director)
  • Permanent representative, Guillaume Wégria (permanent representative)
16-07
NBB filing Annual accounts filed
fiscal year 2025 · full schema
2025
31-12
Financial Weakest financial yearnet -€2.4m
Net result drops to -€2.4m, the lowest in the series.
09-07
NBB filing Annual accounts filed
fiscal year 2024 · full schema
2024
31-12
Financial Liquidity doublescurrent ratio 15.91
Current ratio from 7.79 to 15.91.
31-12
Financial Equity above €10mEq €12.5m ▲668%
Equity rises from €1.6m to €12.5m.
15-07
NBB filing Annual accounts filed
fiscal year 2023 · full schema
2023
20-06
NBB filing Annual accounts filed
fiscal year 2022 · full schema
2022
31-12
Financial Liquidity quadruplescurrent ratio 9.78
Current ratio from 2.27 to 9.78; short-term debt falls from €793,081 to €303,433.
12-07
NBB filing Annual accounts filed
fiscal year 2021 · micro schema
2021
31-12
Financial Back to profitnet €294,844
Net result €294,844 after 3 loss-making years.
29-07
NBB filing Annual accounts filed
fiscal year 2020 · micro schema
Show earlier events
2020
24-08
NBB filing Annual accounts filed
fiscal year 2019 · micro schema · 24 days late
2019
05-08
NBB filing Annual accounts filed
fiscal year 2018 · micro schema · 5 days late
2018
28-06
NBB filing Annual accounts filed
fiscal year 2017 · micro schema
2017
23-08
NBB filing Annual accounts filed
fiscal year 2016 · micro schema · 23 days late
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
1 of 14 acts read
About the unread acts

Of the 14 Belgian State Gazette acts we know for this company, 1 has been read. The other 13 have not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
1 director, last change in 2026
Carlos Rodriguez-Villa Förster
Director · since 25-06-2026
Current
Derived from published Gazette acts. The CBE keeps the official list of function holders; we do not read it, so the two can differ. See the function holders in the CBE →
Not every act has been read: a resignation may be missing here
13 of this company's 14 Belgian State Gazette acts have not been read yet. Appointments and resignations recorded in them are missing above: a director who resigned there may therefore still show here as sitting. The acts are in the Timeline.
Location & real-estate footprint
Registered office, Anderlecht · 3 establishment units since 2014
seat establishment All 3 establishment units on the map
Ground area
9.0 ha
Building footprint
2,820 m²
Volume, LiDAR
18,854 m³
3 parcels, Brussels, Wallonia · tallest building 17.9 m, ±2 floors. Linked by address, not a title deed.
9 companies at this address See who is registered here
3 establishment units
Fyteko
Researchdreef 4, 1070 AnderlechtOther professional, scientific and technical activities
since 20142.230.697.221
FYTEKO
Boulevard André Delvaux 11A, 7000 MonsManufacture of chemicals and chemical products
since 20172.267.735.680
Fyteko
Avenue Jean Monnet 1, 1348 Ottignies-Louvain-la-NeuveScientific research and development
since 20232.342.531.984
3 parcels
Wallonia 2 (66.7%) Brussels 1 (33.3%)
Parcel (capakey) Region Area Buildings Height / fl.
25384A0101/00W000 Wallonia 8.8 ha 1 · 654 m² 8.9 m · 2 fl.
21307F0170/00S002 Brussels 2,186 m² 1 · 2,167 m² 17.9 m · 2 fl.
53402A0191/00F016 Wallonia 400 m² - -
Linked by address, not proof of ownership
Good to know
3 of 3 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Mandate history

2 people since 2026, 1 in office
Show
  • Board
  • began earlier
Mandates per person, with start and end dates
Name Functions and periods
Carlos Rodriguez-Villa Förster
  • Director, from 25-06-2026 to date
Rico TOFT CHRISTENSEN
  • Director, until 25-06-2026
See the board, name and seat on a given date →

Structure & network

Owners and holdings

2 owners

Owners 2

Holdings 0

No holding stated in the accounts, acts or LEI register we read.

According to the annual accounts of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.

Connections & network

1 current director
Depth

The network starts from this company’s directors. Other companies they run appear here as nodes.

This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, scroll to zoom.

Subsidies and aid

European research

1 project · 1 as coordinator · 1,933,269 EUR EU contribution
Programmes
1 entry · 1,933,269 EUR
Projects
Nurspray Biostimulants - Protecting agriculture against climate stress with breakthrough sustainable crop treatment
Horizon 2020 · coordinator · 01-05-2020 to 31-12-2022 · 1,933,269 EUR · NURSPRAY

Recognitions · licences · registrations

Food safety, FASFC

1 site
Mons2.267.735.680
1 permission
Fabrikant andere meststoffen · since 01-02-2023

Similar companies · same sector, comparable size

Of 762 companies in this sector we hold annual accounts for 484. 143 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Company details

Identification
Legal formPublic limited company
Founded23-05-2014
Fiscal year end31-12
Activities, NACEBEL 2025
72101Research and development on biotechnology
72109Other research and development on natural sciences
47761Retail sale of flowers, plants, seeds and fertilisers
71121Engineering and related technical consultancy, excluding land surveyors
74999Other professional, scientific and technical activities
Contact
Website www.fyteko.comAnderlecht
E-mail contact@fyteko.comAnderlecht
Phone 010235411Ottignies-Louvain-la-Neuve
E-invoicing
Reachable via Peppol
Peppol ID 0208:0552915242
Registered 20-11-2020

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 30 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.